Eptifibatide Injection, Solution
Product Images NDC 25021-408

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 25021-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ept01 0001 01)

Structural Formula (Ept01 0001 01)
Chemical structure of eptifibatide showing its molecular arrangement with peptide bonds, sulfur atoms, and cyclic components as typically represented in organic chemistry diagrams.*
FDA Label Image

Figure 1 (Ept01 0001 02)

Figure 1 (Ept01 0001 02)
A line graph comparing the percent of patients with events over time (days) for eptifibatide versus placebo treatments. The x-axis shows time in days from 0 to 30, and the y-axis shows the percent of patients with events from 0 to 16%. The graph includes a solid line for eptifibatide and a dashed line for placebo, illustrating a slower increase in events for eptifibatide compared to placebo over the 30-day period.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ept01 0001 03)

Package Label – Principal Display Panel – Vial Label (Ept01 0001 03)
Label for eptifibatide injection 0.75 mg/mL strength in a 100 mL single-use vial. The label includes the proprietary name, strength, dosage form, and instructions for intravenous use only. It is labeled as sterile, nonpyrogenic, preservative-free, and manufactured by Sagent Pharmaceuticals.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ept01 0001 04)

Package Label – Principal Display Panel – Vial Label (Ept01 0001 04)
Packaging label for Eptifibatide injection by Sagent Pharmaceuticals, strength 20 mg per 10 mL (2 mg per mL) in a 10 mL single-use vial. The label indicates intravenous use only and includes storage and handling instructions along with manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.